Sympathetic activation and nitric oxide function in early hypertension

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 7, 2012, Pages

  Gamboa, Alfredo ^a   Okamoto, Luis E ^a   Diedrich, André ^a   Choi, Leena ^a   Robertson, David ^a   Farley, Ginnie ^a   Paranjape, Sachin ^a   Biaggioni, Italo ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Autonomic; Hypertension; Nervous system; Nitric oxide; Nitric oxide synthase; Sympathetic

Indexed keywords

AMLODIPINE; ATENOLOL; DILTIAZEM; FOSINOPRIL; HYDROCHLOROTHIAZIDE; IRBESARTAN; LISINOPRIL; LOSARTAN; N(G) METHYLARGININE; NITRIC OXIDE; OLMESARTAN; QUINAPRIL; TRIAMTERENE; TRIMETAPHAN; VALSARTAN;

ADULT; ARTICLE; BLOOD VESSEL TONE; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SYMPATHETIC FUNCTION; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGING; BAROREFLEX; BLOOD PRESSURE; ENZYME INHIBITORS; FEMALE; HEART RATE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; NICOTINIC ANTAGONISTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OMEGA-N-METHYLARGININE; RECEPTORS, NICOTINIC; SMOKING; SYMPATHETIC NERVOUS SYSTEM; TRIMETHAPHAN; YOUNG ADULT;

EID: 84859476460     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01020.2011     Document Type: Article

References (31)

1. Berry C, Brosnan MJ, Fennell J, Hamilton CA, Dominiczak AF. Oxidative stress and vascular damage in hypertension. Curr Opin Nephrol Hypertens 10: 247-255, 2001.
2. Calver A, Collier J, Moncada S, Vallance P. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens 10: 1025-1031, 1992.
3. Charkoudian N, Joyner MJ, Barnes SA, Johnson CP, Eisenach JH, Dietz NM, Wallin BG. Relationship between muscle sympathetic nerve activity and systemic hemodynamics during nitric oxide synthase inhibition in humans. Am J Physiol Heart Circ Physiol 291: H1378-H1383, 2006.
4. Diedrich A, Jordan J, Tank J, Shannon JR, Robertson R, Luft FC, Robertson D, Biaggioni I. The sympathetic nervous system in hypertension: assessment by blood pressure variability and ganglionic blockade. J Hypertens 21: 1677-1686, 2003.
5. Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet 349: 837-842, 1997.
6. Gamboa A, Shibao C, Diedrich A, Choi L, Pohar B, Jordan J, Paranjape S, Farley G, Biaggioni I. Contribution of endothelial nitric oxide to blood pressure in humans. HTN 49: 170-177, 2007.
7. Grassi G, Seravalle G, Quarti-Trevano F, Mineo C, Lonati L, Facchetti R, Mancia G. Reinforcement of the adrenergic overdrive in the metabolic syndrome complicated by obstructive sleep apnea. J Hypertens 28: 1313-1320, 2010.
8. Hansen J, Jacobsen TN, Victor RG. Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans? HTN 24: 439-444, 1994.
9. Hijmering ML, Stroes ESG, Olijhoek J, Hutten BA, Blankestijn PJ, Rabelink TJ. Sympathetic activation markedly reduces endotheliumdependent, flow-mediated vasodilation. J Am Coll Cardiol 39: 683-688, 2002.
10. Jacobi J, Schneider MP, John S, Schmieder RE. Impact of NO-synthase inhibition on renal hemodynamics in normotensive and hypertensive subjects. J Hypertens 20: 525-530, 2002.
11. Kubicek WG, From AH, Patterson RP, Witsoe DA, Castaneda A, Lillehei RC, Ersek R. Impedance cardiography as a noninvasive means to monitor cardiac function. J Assoc Adv Med Instrum 4: 79-84, 1970.
12. Linder L, Kiowski W, Buhler FR, Luscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. Circulation 81: 1762-1767, 1990.
13. Mayer BX, Mensik C, Krishnaswami S, Derendorf H, Eichler HG, Schmetterer L, Wolzt M. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans. Br J Clin Pharmacol 47: 539-544, 1999.
14. Oppenheimer D. Neuropathology of autonomic failure. In: Autonomic Failure A Textbook of Clinical Disorders of the Autonomic Nervous System, edited by Bannister R. Oxford, UK: Oxford Medical Publications, 1988, p. 451-463.
15. Owlya R, Vollenweider L, Trueb L, Sartori C, Lepori M, Nicod P, Scherrer U. Cardiovascular and sympathetic effects of nitric oxide inhibition at rest and during static exercise in humans. Circulation 96: 3897-3903, 1997.
16. Pan J, Tompkins WJ. A real-time QRS detection algorithm. IEEE Trans Biomed Eng 32: 230-236, 1985.
17. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323: 22-27, 1990.
18. Panza JA, Quyyumi AA, Callahan TS, Epstein SE. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol 21: 1145-1151, 1993.
19. Sakima A, Teruya H, Yamazato M, Matayoshi R, Muratani H, Fukiyama K. Prolonged NOS inhibition in the brain elevates blood pressure in normotensive rats. Am J Physiol Regul Integr Comp Physiol 275: R410-R417, 1998.
20. Sakuma I, Togashi H, Yoshioka M, Saito H, Yanagida M, Tamura M, Kobayashi T, Yasuda H, Gross SS, Levi R. NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone? Circ Res 70: 607-611, 1992.
21. Sander M, Chavoshan B, Victor RG. A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension 33: 937-942, 1999.
22. Sander M, Hansen PG, Victor RG. Sympathetically mediated hypertension caused by chronic inhibition of nitric oxide. Hypertension 26: 691-695, 1995.
23. Seddon MD, Chowienczyk PJ, Brett SE, Casadei B, Shah AM. Neuronal nitric oxide synthase regulates basal microvascular tone in humans in vivo. Circulation 117: 1991-1996, 2008.
24. Shankar R, Zhu JS, Ladd B, Henry D, Shen HQ, Baron AD. Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action. J Clin Invest 102: 1403-1412, 1998.
25. Shibao C, Gamboa A, Diedrich A, Ertl AC, Chen KY, Byrne DW, Farley G, Paranjape SY, Davis SN, Biaggioni I. Autonomic contribution to blood pressure and metabolism in obesity. Hypertension 49: 27-33, 2007.
26. Taddei S, Virdis A, Mattei P, Salvetti A. Vasodilation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 21: 929-933, 1993.
27. Task Force of the European Society of Cardiology, the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 93: 1043-1065, 1996.
28. Topal E, Cikim AS, Cikim K, Temel I, Ozdemir R. The effect of moxonidine on endothelial dysfunction in metabolic syndrome. Am J Cardiovasc Drugs 6: 343-348, 2006.
29. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2: 997-1000, 1989.
30. Wenzel RR, Spieker L, Qui S, Shaw S, Luscher TF, Noll G. I1-imidazoline agonist moxonidine decreases sympathetic nerve activity and blood pressure in hypertensives. Hypertension 32: 1022-1027, 1998.
31. Young CN, Fisher JP, Gallagher KM, Whaley-Connell A, Chaudhary K, Victor RG, Thomas GD, Fadel PJ. Inhibition of nitric oxide synthase evokes central sympatho-excitation in healthy humans. J Physiol Lond 587: 4977-4986, 2009.